Navigation Links
First Suit Against Nobel Prize Organization Citing Defamation And Unfair Competition Practices Is Filed
Date:12/6/2012

LOS ANGELES, Dec. 6, 2012 /PRNewswire/ -- Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life scientist and medical scientist, has filed a lawsuit today against The Nobel Assembly at Karolinska Institutet, a Swedish corporation, aka, Nobelforsamlingen. The Nobel Assembly at Karolinska Institutet is a body which awards the Nobel Prize in Physiology or Medicine. The suit filed in Superior Court of the State of California, Orange County Central Justice Center cites Libel and unfair competition.

Dr. Xu, one of the leading scientists in the world, discovered in 1984 the existence of "regenerative cell" which was confirmed to be keratin-19 positive stem cell after 2000 (US patent 6991813B2), during his study of burn treatments that has benefited 20 million burn victims in 73 countries, claims his good reputation in the community was defamed by a statement published by defendants, The Nobel Assembly, causing damages to Dr. Xu by their conduct. The suit alleges The Nobel Assembly has been successful in garnering media attention for their Nobel Prize announcements in essentially every major news organizations and publications world-wide, proving they can affect the perception of an individual by misreporting information.

"My main priority for filing this suit was to clarify the Academy's mistaken and misleading statements for the preservation of humanity and future generations, life science research should not desecrate the nature of human life," stated Dr. Xu.

On October 8, 2012, The Nobel Prize in Physiology or Medicine 2012 was awarded jointly to Sir John B. Gurdon and Shinya Yamanaka "for the discovery that mature cells can be reprogrammed to become pluripotent," which was covered extensively in the media. 

In an abstract published on its website made in conjunction with the selection, The Nobel Assembly described the scientists' discovery.  The Nobel Assembly
'/>"/>

SOURCE Mebo International
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Topokine Announces Dosing of First Subject in a Phase I Clinical Trial of XAF5 Gel for Local Reduction of Subcutaneous Fat
2. Karmanos Cancer Center first in Midwest to offer latest Molecular Breast Imaging
3. China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013
4. First Effective Treatment For Traumatic Brain Injury Reported by Institute of Neurological Recovery, Even Years After Injury
5. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on November 14, 2012
6. First noiseless single photon amplifier
7. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2013 Financial Results
8. Elektas Monaco System Used for First Time to Create VMAT Plan for Delivery on Varian Treatment System
9. Palatin Technologies, Inc. To Report Fiscal Year 2013 First Quarter Results; Teleconference and Webcast to be held on November 14, 2012
10. First Neurally Controlled, Powered Prosthetic Limb Is 2,109 Steps Closer To Realization
11. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... VANCOUVER , March 31, 2015  /PRNewswire/ - ESSA ... today that it has filed with the Food and ... Drug ("IND") application related to the Company,s proposed clinical ... the IND application is required in order for ESSA ... The IND application is a complete ...
(Date:3/31/2015)... FRANCISCO , March 31, 2015  Sonoa Health, ... Australia , has developed a world-first consumer health ... records, medication prescriptions, wearable devices and more. ... Stewart as its CEO, who brings to the ... corporate advisory, which has included working closely with the ...
(Date:3/31/2015)... NEW YORK , March 31, 2015 /PRNewswire/ ... biopharmaceutical company advancing protein biologic therapies and oncology ... marketing partner, Hanmi Pharmaceutical Co., Ltd ("Hanmi") (KSE: ... the country,s Ministry of Food and Drug Safety ... (KTR) for MuGard, its oncology supportive-care treatment for ...
(Date:3/31/2015)... March 31, 2015 Diasome Pharmaceuticals, Inc. ... SDG, Inc., that a United States patent has recently ... therapy. , Entitled “Lipid Construct for Delivery ... of matter claims related to the use of Diasome’s ... enabling injected insulin to more effectively reach the liver’s ...
Breaking Biology Technology:ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 2ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 3ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 4Investment Banker Appointed CEO of Australian Health Tech Start-Up 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 3PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2
... researchers have successfully synthesized a DNA-based memory loop in ... in the emerging field of synthetic biology. , ... in the lab of Professor Pamela Silver, a faculty ... not only reconstructed the dynamics of memory, but also ...
... Sept. 14 Viragen, Inc. (OTC,Bulletin Board: ... (OTC Bulletin Board: VRGE), today jointly announced,that ... Umea, Sweden, filed an application seeking protection ... Multiferon(R), a,multi-subtype, human alpha interferon. The ...
... September 14, Rosetta Genomics Ltd (Nasdaq: ROSG ... and therapeutics, announced,today that Amir Avniel, Rosetta Genomics, ... Thursday, September 20, at 5:00 pm EDT at ... live audio webcast of the presentation will be ...
Cached Biology Technology:Scientists synthesize memory in yeast cells 2Scientists synthesize memory in yeast cells 3Viragen International's Subsidiary, ViraNative AB, Files to Seek Bankruptcy Protection in Sweden 2Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference 2
(Date:3/18/2015)... 18, 2015 As mobile payments become ... smart wallets and apps continue to be introduced into the ... the mobile payment industry in focus today are:  NXT-ID, Inc. ... BABA ), Apple Inc. (NASDAQ: AAPL ... Inc. (NASDAQ: FB ) NXT-ID, Inc. ...
(Date:3/16/2015)... 16, 2015 Between 16 ... present groundbreaking innovations in biometric identification at the ... .      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ... is well at the forefront: the company,s all ... in Germany . BiometricGate is ...
(Date:3/12/2015)... VIEW, Calif. , March 12, 2015 /PRNewswire/ ... with Complimentary Registration here: http://bit.ly/1G7Os0L . SPEAKERS: ... Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... in order to compete in several different markets ... market is currently witnessing an uptrend. ...
Breaking Biology News(10 mins):Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
... May 22, 2013 Early screening for prostate cancer could ... for women, thanks to UC Irvine research published today in ... After more than a decade of work, UC Irvine chemists ... for prostate cancer in urine, meaning that the disease could ...
... concept of "place" is increasingly being considered in the ... new resource that can help them recognize and respond ... their lives. Place-Based Conservation: Perspectives from the ... Northwest Research Station,s Linda Kruger, can help managers take ...
... Mo. Cancers of all types become most deadly when ... has reached this stage, it becomes very difficult for doctors ... Now, researchers at the University of Missouri have found a ... wherever they may be in the body. Michael Lewis, an ...
Cached Biology News:UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3MU researchers develop radioactive nanoparticles that target cancer cells 2
Mouse H60 Allophycocyanin MAb (Clone 205326) ENTREZ GeneID: 15101...
... 250 ul (125 precipitations). ... easy pellet location.Efficient precipitation ... inert, compatible with most ... protocol. Category: DNA/RNA Synthesis ...
... controls for monitoring Aldolase tests. 2 ... with targeted manufacturing values at 4 ... 3 IU/L. 30-day shelf life ... C. Level 1: 3 x 3 ...
EDTA, 0.5 M solution, 100 ml. Ethylene diaminetetraacetic acid.Sterile, nuclease-free. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: